TFB Advisors »

Protagonist Therapeutics shares owned by TFB Advisors

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by TFB Advisors from 13F filings

Historical chart of TFB Advisors investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by TFB Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by TFB Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $231k 2.2k 105.40

More positions owned by TFB Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard World Mega Grwth Ind (MGK)
Ishares Tr Core S&p500 Etf (IVV)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Vanguard World Mega Cap Val Etf (MGV)
Ishares Tr Core Msci Eafe (IEFA)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Small Cp Etf (VB)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Vanguard Whitehall Fds High Div Yld (VYM)
Vanguard Index Fds Mcap Vl Idxvip (VOE)
Spdr Series Trust State Street Spd (BIL)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for TFB Advisors

Top funds holding Protagonist Therapeutics

BlackRock
Farallon Capital Management
Vanguard Group
UBS Group
Rtw Investments
Vanguard Portfolio Management
State Street Corporation
Wellington Management Company
Henderson Group
Johnson & Johnson
Invesco
Geode Capital Management
Citadel Advisors
Woodline Partners
Bank of America Corporation

View all funds holding Protagonist Therapeutics